🇺🇸 FDA
Patent

US 8088729

Anti-viral griffithsin compounds, compositions and methods of use

granted A61KA61K38/168A61P

Quick answer

US patent 8088729 (Anti-viral griffithsin compounds, compositions and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/168, A61P, A61P31/12